Literature DB >> 7687892

Constitutive expression of steel factor gene by human stromal cells.

M C Heinrich1, D C Dooley, A C Freed, L Band, M E Hoatlin, W W Keeble, S T Peters, K V Silvey, F S Ey, D Kabat.   

Abstract

Steel factor (SF), the ligand for c-kit, is an essential regulator of normal hematopoiesis, melanogenesis, gametogenesis, and mast-cell growth and development. Hematopoietic stromal cells are important sources of SF, because inactivation of SF in mice results in defects in the support function of hematopoietic stromal cells. To identify specific cells that produce, and factors that govern the expression of the different isoforms of SF in human hematopoiesis, we quantified levels of SF mRNA and membrane-bound protein in human stromal cells before and after exposure to recombinant human interleukin (IL)-1 alpha, a cytokine known to induce the expression of a variety of hematopoietic growth factors. In addition, because stromal cells in longterm bone marrow cultures (LTBMC) are supportive of hematopoietic progenitor cell survival in vitro, while umbilical vein endothelial cells (EC) and diploid fibroblasts (DF) are not, we also sought to test the hypothesis that SF gene expression would differ in cells from LTBMC when compared with EC or DF. Using reverse-transcription polymerase chain reaction amplification (RT-PCR), ribonuclease protection assays (RPA), and Northern blot analysis, SF was found to be constitutively transcribed in EC, DF, and LTBMC. IL-1 alpha neither induced accumulation of SF mRNA nor altered the ratio of exon 6+ to exon 6- transcripts in these stromal cells. By Northern blot analysis, the predominant SF mRNA species was shown to be 5.6 kb; a minor population of 3.6 kb was also found. Low levels of membrane-bound SF protein were found to be constitutively expressed by all three types of stromal cells, and were not regulated by IL-1 alpha. We conclude that the unique capacity of LTBMC to support in vitro hematopoiesis, when compared with EC or DF, cannot be explained on the basis of qualitative or quantitative differences in SF gene expression in these cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687892

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis.

Authors:  Pilar Peris; Matthew M Roforth; Kristy M Nicks; Daniel Fraser; Koji Fujita; Robert L Jilka; Sundeep Khosla; Ulrike McGregor
Journal:  J Cell Biochem       Date:  2015-01       Impact factor: 4.429

Review 2.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

3.  Serum Stem Cell Factor Level Predicts Decline in Kidney Function in Healthy Aging Adults.

Authors:  W Zhang; L Jia; D L X Liu; L Chen; Q Wang; K Song; S Nie; J Ma; X Chen; M Xiu; M Gao; D Zhao; Y Zheng; S Duan; Z Dong; Z Li; P Wang; B Fu; G Cai; X Sun; X Chen
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 4.  Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques.

Authors:  M E Hoatlin; S L Kozak; C Spiro; D Kabat
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

5.  Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury.

Authors:  Luis F Miranda; Claudia O Rodrigues; Shalini Ramachandran; Eneida Torres; Jian Huang; Jammie Klim; Dorothy Hehre; Ian McNiece; Joshua M Hare; Cleide Y Suguihara; Karen C Young
Journal:  Pediatr Res       Date:  2013-10-23       Impact factor: 3.756

6.  Human FANCC is hypomorphic in murine Fancc-deficient cells.

Authors:  Laura E Hays; Winifred W Keeble; Jane E Yates; R K Rathbun; Tara Koretsky; Susan B Olson; Zejin Sun; D Wade Clapp; Grover C Bagby
Journal:  Blood       Date:  2010-06-16       Impact factor: 22.113

7.  Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.

Authors:  Ashlee V Moses; Michael A Jarvis; Camilo Raggo; Yolanda C Bell; Rebecca Ruhl; B G Mattias Luukkonen; Diana J Griffith; Cecily L Wait; Brian J Druker; Michael C Heinrich; Jay A Nelson; Klaus Früh
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls.

Authors:  S C Bischoff; S Schwengberg; K Wordelmann; A Weimann; R Raab; M P Manns
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

Review 9.  The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke.

Authors:  Li R Zhao; Chun S Piao; Sasidhar R Murikinati; Maria E Gonzalez-Toledo
Journal:  Recent Pat CNS Drug Discov       Date:  2013-04

10.  Oestrogen-deficiency inducing haematopoiesis dysfunction via reduction in haematopoietic stem cells and haematopoietic growth factors in rats.

Authors:  Xi Qiu; Xiang-Gui Yuan; Xiao-Li Jin; Xin He; Lei Zhu; Xiao-Ying Zhao
Journal:  Int J Exp Pathol       Date:  2012-06       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.